Drug Search Results
More Filters [+]

Tolnaftate

Alternative Names: tolnaftate
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Bangladesh | Brazil | Canada | Chile | Colombia | Dominican Republic | Egypt | France | Hong Kong | Hungary | India | Ireland | Israel | Italy | Korea | Malaysia | Malta | Mexico | New Zealand | Peru | Philippines | Portugal | Singapore | South Africa | Spain | Sri Lanka | Taiwan | Tunisia | Turkey | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tolnaftate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title